SpectrumAi, a digital health company that develops innovative solutions in the autism space, announced it raised $9 million in a funding round co-led by F-Prime Capital and Frist Cressey Ventures, with an additional investment from Autism Impact Fund. SpectrumAi’s technology aims to improve the quality of applied behavior analysis (ABA) therapy. The company plans to use the new funding to capture objective ABA data. “When used properly, ABA therapy can have a significant positive impact on a child’s life and their family; utilized poorly, ABA can actually be harmful. The unfortunate reality is that there are no universally accepted objective…
Content Restricted
You must be a Free or Elite member to view this resource.
Log In | Sign up or learn more about membership options.
